Τρίτη 25 Απριλίου 2017

Early stage breast cancer treatment and prognostic factors

Summary

Developments in early breast cancer presented at the 2016 San Antonio Breast Cancer Symposium included important studies on extending adjuvant endocrine therapy with aromatase inhibitors, the role of bisphosphonates, and evidence for molecular prognostic factors and circulating tumor cells in early stage breast cancer patients.



from Cancer via ola Kala on Inoreader http://ift.tt/2pdzC88
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου